Sgltr Tablets 100 mg contain Remogliflozin Etabonate, an oral antidiabetic agent belonging to the SGLT2 (sodium-glucose co-transporter-2) inhibitor class. It is used to manage type 2 diabetes mellitus by promoting the excretion of excess glucose through urine, thereby lowering blood sugar levels. Sgltr also supports weight loss and may contribute to blood pressure reduction, making it a beneficial choice for patients with coexisting metabolic conditions.

• Effectively reduces blood glucose levels in type 2 diabetes

• Aids in weight management through calorie loss in urine

• Helps lower blood pressure slightly due to its diuretic effect

• Can be used as monotherapy or in combination with other oral antidiabetic agents

• Improves glycemic control without causing significant hypoglycemia

• Take one tablet (100 mg) orally twice daily, preferably before meals

• Swallow the tablet whole with water

• Follow your healthcare provider’s dosage and timing instructions carefully

• Maintain a balanced diet and regular exercise for optimal results

• Usual adult dose: 100 mg twice daily

• May be used alone or in combination with other antidiabetic medications such as metformin

• Do not skip or double doses; if a dose is missed, take it as soon as you remember unless it's close to the next scheduled dose

• Not intended for patients with type 1 diabetes or diabetic ketoacidosis

• Use with caution in patients with renal impairment or frequent urinary tract infections

• Stay well-hydrated to prevent dehydration, especially in hot weather or during exercise

• Inform your doctor if pregnant, planning pregnancy, or breastfeeding

• Monitor kidney function and blood sugar levels regularly during therapy

• Common side effects:

• Increased urination

• Urinary tract infections

• Less common but serious side effects:

• Dehydration and dizziness

• Hypotension (low blood pressure)

• Increased risk of ketoacidosis (rare)

• Kidney function changes (monitor if at risk)

•  

• Genital fungal infections

• Thirst and dry mouth

• Store at room temperature between 15°C to 30°C

• Protect from moisture and direct sunlight

• Keep in the original packaging

• Keep out of reach of children

Q1. What is Sgltr used for?
Sgltr (Remogliflozin) is used to lower blood sugar levels in adults with type 2 diabetes.

Q2. Can Sgltr cause hypoglycemia?
The risk of hypoglycemia is low when used alone, but may increase when combined with insulin or sulfonylureas.

Q3. Is Sgltr safe for patients with kidney problems?
Caution is advised in patients with moderate to severe kidney disease. Kidney function should be monitored regularly.

Q4. Does Sgltr help with weight loss?
Yes, many patients experience mild to moderate weight loss due to the glucose-lowering and diuretic effect.